NCT04679948View on ClinicalTrials.gov

A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

December 21, 2020

Primary Completion Date

March 17, 2021

Study Completion Date

March 17, 2021

Conditions
Healthy
Interventions
DRUG

Percoffedrinol®

Tablet

DRUG

Coumadin®

Tablet

DRUG

Antra MUPS®

Gastro-resistant tablet

DRUG

Midazolam-ratiopharm®

Oral solution

DRUG

BI 730357

Film-coated tablet

Trial Locations (1)

88397

Humanpharmakologisches Zentrum Biberach, Biberach

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04679948 - A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood | Biotech Hunter | Biotech Hunter